NO883986D0 - Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. - Google Patents
Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.Info
- Publication number
- NO883986D0 NO883986D0 NO883986A NO883986A NO883986D0 NO 883986 D0 NO883986 D0 NO 883986D0 NO 883986 A NO883986 A NO 883986A NO 883986 A NO883986 A NO 883986A NO 883986 D0 NO883986 D0 NO 883986D0
- Authority
- NO
- Norway
- Prior art keywords
- acridinamines
- alkylide
- tetrahydro
- medicines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9393587A | 1987-09-08 | 1987-09-08 | |
| US07/223,846 US5013741A (en) | 1987-09-08 | 1988-07-25 | N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO883986D0 true NO883986D0 (no) | 1988-09-07 |
| NO883986L NO883986L (no) | 1989-03-09 |
Family
ID=26788073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO88883986A NO883986L (no) | 1987-09-08 | 1988-09-07 | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5013741A (no) |
| EP (1) | EP0306825B1 (no) |
| JP (1) | JP2641915B2 (no) |
| KR (1) | KR890005058A (no) |
| AU (1) | AU620043B2 (no) |
| CA (1) | CA1334669C (no) |
| DE (1) | DE3889043T2 (no) |
| DK (1) | DK167251B1 (no) |
| ES (1) | ES2053652T3 (no) |
| FI (1) | FI89478C (no) |
| HU (1) | HU201017B (no) |
| IE (1) | IE63027B1 (no) |
| IL (1) | IL87679A0 (no) |
| NO (1) | NO883986L (no) |
| NZ (1) | NZ226054A (no) |
| PT (1) | PT88444B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868177A (en) * | 1988-11-09 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use |
| JPH02180871A (ja) * | 1988-11-16 | 1990-07-13 | Hoechst Roussel Pharmaceut Inc | ヒドロキシ―１，２，３，４―テトラヒドロアミノアクリジンおよびその製造法 |
| FR2640508B1 (fr) * | 1988-12-19 | 1994-07-01 | Dietlin Francois | Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire |
| US5175172A (en) * | 1988-12-19 | 1992-12-29 | Francois Dietlin | Method of alleviating AIDS symptoms and compositions therefor |
| US5149813A (en) * | 1989-06-26 | 1992-09-22 | Hoechst-Roussel Pharmaceuticals Incorporated | Process for (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds |
| JPH09500645A (ja) * | 1993-07-22 | 1997-01-21 | ワーナー−ランバート・コンパニー | 制御放出タクリン薬物送達システムおよびその製造方法 |
| CN108047202B (zh) * | 2017-12-20 | 2021-06-11 | 东南大学 | 一种铝离子响应型化合物及其制备方法与应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3232945A (en) * | 1962-08-13 | 1966-02-01 | S E Massengill Company | 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines |
| US3318896A (en) * | 1963-12-05 | 1967-05-09 | Squibb & Sons Inc | Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines |
| US3318895A (en) * | 1963-12-05 | 1967-05-09 | Squibb & Sons Inc | Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines |
| BE658695A (no) * | 1964-02-03 | 1965-07-22 | ||
| US3541066A (en) * | 1968-09-16 | 1970-11-17 | American Home Prod | 2,3-dihydro-1,4-ethanobenzo(b)(1,5)naphthyridine derivatives |
| US3580915A (en) * | 1968-09-16 | 1971-05-25 | American Home Prod | 1,2,3,4-tetrahydrobenzol(b)(1,6)naphthyridine derivatives |
| US3647800A (en) * | 1970-04-30 | 1972-03-07 | American Home Prod | 10-substituted - 1 2 3 4 - tetrahydrobenzo(b)(1 6)naphthyridines useful as cns depressants |
| US3637706A (en) * | 1970-04-30 | 1972-01-25 | American Home Prod | 10-(4 - (lower)alkylpiperazino) - 1 2 3 4-tetrahydrobenzo(b)(1 6) naphthyridine derivatives useful as cns depressants |
| US3657233A (en) * | 1970-04-30 | 1972-04-18 | American Home Prod | 10-morpholino-1 2 3 4-tetrahydrobenzo(b)(1 6)naphthyridine derivatives |
| US3674790A (en) * | 1970-05-01 | 1972-07-04 | American Home Prod | 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants |
| ES431307A1 (es) * | 1973-11-16 | 1976-09-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos derivados de quinoleina. |
| US4108998A (en) * | 1976-11-08 | 1978-08-22 | American Home Products Corp. | Furo[3,4-b]quinoline derivatives and pharmaceutical compositions and methods employing them |
| US4575553A (en) * | 1984-06-18 | 1986-03-11 | Bristol-Myers Company | Antitumor m-AMSA analog |
| US4631286A (en) * | 1984-10-25 | 1986-12-23 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
| US4695573A (en) * | 1984-10-25 | 1987-09-22 | Hoechst-Roussel Pharmaceuticals Inc. | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds |
| DE3582995D1 (de) * | 1984-10-25 | 1991-07-04 | Hoechst Roussel Pharma | 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel. |
| US4816456A (en) * | 1986-10-01 | 1989-03-28 | Summers William K | Administration of monoamine acridines in cholinergic neuronal deficit states |
| EP0268871A1 (en) * | 1986-10-31 | 1988-06-01 | Sumitomo Pharmaceuticals Company, Limited | Quinoline derivatives |
| US4762841A (en) * | 1987-03-30 | 1988-08-09 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes) |
| US4851536A (en) * | 1987-05-07 | 1989-07-25 | American Home Products Corporation | Cyclohexylquinolines as inhibitors of interleukin 1 |
| IL87861A0 (en) * | 1987-10-05 | 1989-03-31 | Pfizer | 4-aminopyridine derivatives |
| WO1989002739A1 (en) * | 1987-10-05 | 1989-04-06 | Pfizer Inc. | 4-aminopyridine derivatives |
| DE3889302T2 (de) * | 1987-12-03 | 1994-10-20 | Mitsubishi Chem Ind | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. |
-
1988
- 1988-07-25 US US07/223,846 patent/US5013741A/en not_active Expired - Lifetime
- 1988-09-01 ES ES88114248T patent/ES2053652T3/es not_active Expired - Lifetime
- 1988-09-01 EP EP88114248A patent/EP0306825B1/en not_active Expired - Lifetime
- 1988-09-01 DE DE3889043T patent/DE3889043T2/de not_active Expired - Fee Related
- 1988-09-06 FI FI884104A patent/FI89478C/fi not_active IP Right Cessation
- 1988-09-06 NZ NZ226054A patent/NZ226054A/xx unknown
- 1988-09-06 IL IL87679A patent/IL87679A0/xx not_active IP Right Cessation
- 1988-09-07 DK DK497888A patent/DK167251B1/da not_active IP Right Cessation
- 1988-09-07 CA CA000576693A patent/CA1334669C/en not_active Expired - Fee Related
- 1988-09-07 KR KR1019880011521A patent/KR890005058A/ko not_active Application Discontinuation
- 1988-09-07 JP JP63222590A patent/JP2641915B2/ja not_active Expired - Fee Related
- 1988-09-07 NO NO88883986A patent/NO883986L/no unknown
- 1988-09-07 IE IE270388A patent/IE63027B1/en not_active IP Right Cessation
- 1988-09-07 PT PT88444A patent/PT88444B/pt not_active IP Right Cessation
- 1988-09-07 AU AU21936/88A patent/AU620043B2/en not_active Ceased
- 1988-09-08 HU HU884630A patent/HU201017B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU620043B2 (en) | 1992-02-13 |
| IL87679A0 (en) | 1989-02-28 |
| FI89478C (fi) | 1993-10-11 |
| DK497888D0 (da) | 1988-09-07 |
| PT88444B (pt) | 1992-10-30 |
| NZ226054A (en) | 1991-08-27 |
| KR890005058A (ko) | 1989-05-11 |
| DE3889043T2 (de) | 1994-10-06 |
| IE882703L (en) | 1989-03-08 |
| DK497888A (da) | 1989-03-09 |
| JP2641915B2 (ja) | 1997-08-20 |
| US5013741A (en) | 1991-05-07 |
| FI884104A0 (fi) | 1988-09-06 |
| PT88444A (pt) | 1989-07-31 |
| CA1334669C (en) | 1995-03-07 |
| DK167251B1 (da) | 1993-09-27 |
| FI89478B (fi) | 1993-06-30 |
| NO883986L (no) | 1989-03-09 |
| DE3889043D1 (de) | 1994-05-19 |
| IE63027B1 (en) | 1995-03-22 |
| JPH01131160A (ja) | 1989-05-24 |
| HUT49332A (en) | 1989-09-28 |
| FI884104A (fi) | 1989-03-09 |
| EP0306825A1 (en) | 1989-03-15 |
| AU2193688A (en) | 1989-03-09 |
| HU201017B (en) | 1990-09-28 |
| ES2053652T3 (es) | 1994-08-01 |
| EP0306825B1 (en) | 1994-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO892083L (no) | Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner. | |
| NO871640D0 (no) | Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater. | |
| NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
| NO890269D0 (no) | Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser. | |
| NO894539D0 (no) | Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater. | |
| NO871052L (no) | 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse. | |
| NO880473L (no) | Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel. | |
| NO893826D0 (no) | Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater. | |
| NO874850D0 (no) | Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav. | |
| NO900643L (no) | Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater. | |
| NO165104C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
| NO883986L (no) | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. | |
| NO167807C (no) | Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater. | |
| NO903347D0 (no) | Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener. | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| NO891574L (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
| NO894516L (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. | |
| NO882028L (no) | Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner. | |
| NO880409D0 (no) | Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler. | |
| NO871484D0 (no) | Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider. | |
| NO883987L (no) | Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. | |
| NO901892D0 (no) | Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter. | |
| NO891987D0 (no) | Fremgangsmaate for fremstilling av n-substituerte fenyltioaniliner, fenylsulfinylaniliner og fenylsulfonylaniliner. | |
| NO913388L (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. | |
| NO883525D0 (no) | Framgangsmaate for framstilling av 1,5-benzotiazepinderivater. |